Is TRIPS preventing vulnerable countries from accessing basic drugs? The case of South Africa Is TRIPS preventing vulnerable countries from accessing basic drugs?  The case of South Africa Reviewed by Neil Wilkof on Friday, November 10, 2017 Rating: 5
Who is going to win the big EU Commission SEP licensing battle - "use-based" or "licence to all"? Who is going to win the big EU Commission SEP licensing battle - "use-based" or "licence to all"?  Reviewed by Annsley Merelle Ward on Thursday, November 09, 2017 Rating: 5
Swiss Supreme Court weighs in on K = Na Swiss Supreme Court weighs in on K = Na Reviewed by Mark Schweizer on Thursday, November 09, 2017 Rating: 5
The protection of vehicles using trade marks and registered designs - London Taxis vs Scooters The protection of vehicles using trade marks and registered designs - London Taxis vs Scooters Reviewed by Rosie Burbidge on Thursday, November 09, 2017 Rating: 5
K = Na. Is the genie out of the bottle? PART 2 K = Na. Is the genie out of the bottle? PART 2 Reviewed by Eibhlin Vardy on Thursday, November 09, 2017 Rating: 5
Beware the special requirements of software protection in Brazil Beware the special requirements of software protection in Brazil Reviewed by Neil Wilkof on Wednesday, November 08, 2017 Rating: 5
K = Na. Is the genie out of the bottle? PART 1 K = Na. Is the genie out of the bottle? PART 1 Reviewed by Eibhlin Vardy on Wednesday, November 08, 2017 Rating: 5
Düsseldorf Court of Appeal in SISVEL v Haier publishes "guidebook" to SEP litigation under Huawei/ZTE Düsseldorf Court of Appeal in SISVEL v Haier publishes "guidebook" to SEP litigation under Huawei/ZTE Reviewed by Annsley Merelle Ward on Tuesday, November 07, 2017 Rating: 5
The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious Reviewed by Annsley Merelle Ward on Sunday, November 05, 2017 Rating: 5
Powered by Blogger.